1. Home
  2. NTCT vs AVDL Comparison

NTCT vs AVDL Comparison

Compare NTCT & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

HOLD

Current Price

$27.77

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.43

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTCT
AVDL
Founded
1984
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
NTCT
AVDL
Price
$27.77
$21.43
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$32.00
$18.38
AVG Volume (30 Days)
492.9K
2.8M
Earning Date
01-29-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.24
N/A
Revenue
$862,770,000.00
$248,517,000.00
Revenue This Year
$5.90
$65.47
Revenue Next Year
$2.62
$30.88
P/E Ratio
$22.19
N/A
Revenue Growth
9.60
79.88
52 Week Low
$18.12
$6.38
52 Week High
$30.67
$23.57

Technical Indicators

Market Signals
Indicator
NTCT
AVDL
Relative Strength Index (RSI) 56.70 59.42
Support Level $27.44 $21.34
Resistance Level $28.20 $21.55
Average True Range (ATR) 0.53 0.24
MACD 0.10 -0.24
Stochastic Oscillator 76.37 13.46

Price Performance

Historical Comparison
NTCT
AVDL

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: